DUBLIN--(BUSINESS WIRE)--The "Cardiovascular Implants Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's offering.
The global cardiovascular implants market was worth US$ 19.8 Billion in 2018. Looking forward, the market value is projected to exceed US$ 27.1 Billion by 2024, expanding at a CAGR of around 5% during 2019-2024.
Rising prevalence of cardiovascular disorders represents a key factor driving the demand of cardiovascular implants. Catalyzed by unhealthy diets and sedentary lifestyles, the prevalence of various cardiovascular disorders has increased across both developed and developing countries.
Improving efficacy and safety of cardiovascular implants represents another major factor spurring the market growth. For instance, recent advancements in technology have opened opportunities for developing smart stent devices which can improve the diagnosis as well treatment of previously unmanageable conditions such as atherosclerosis and central line access failure.
Apart from this, various government and non-profit organizations are also taking initiatives to improve the affordability of these devices. Other factors driving this market include ageing population, development in medical infrastructure, growing awareness levels and rising popularity of minimally invasive surgeries.
Key Questions Answered
- How has the global cardiovascular implants market performed so far and how will it perform in the coming years?
- What is the breakup of the global cardiovascular implants market on the basis of region?
- What is the breakup of the global cardiovascular implants market on the basis of product?
- What is the breakup of the global cardiovascular implants market on the basis of material?
- What is the breakup of the global cardiovascular implants market on the basis of procedure type?
- What is the breakup of the global cardiovascular implants market on the basis of indication?
- What are the various stages in the value chain of the global cardiovascular implants market?
- What are the key driving factors and challenges in the global cardiovascular implants market?
- What is the structure of the global cardiovascular implants market and who are the key players?
- What is the degree of competition in the global cardiovascular implants market?
Topics Covered
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.4 Market Estimation
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Properties
4.3 Key Industry Trends
5 Global Cardiovascular Implants Market
5.1 Market Overview
5.2 Market Performance
5.3 Market Breakup by Product
5.4 Market Breakup by Material
5.5 Market Breakup by Procedure Type
5.6 Market Breakup by Indication
5.7 Market Breakup by Region
5.8 Market Forecast
6 Market Breakup by Product
6.1 Coronary Stent
6.2 ICD
6.3 Heart Valve
6.4 Implanted Cardiac Pacemaker
6.5 CRT Device
6.6 Peripheral Stent
7 Market Breakup by Material
7.1 Metals and Alloys
7.2 Polymers
7.3 Biological Materials
8 Market Breakup by Procedure Type
8.1 Angioplasty
8.2 Open Heart Surgery
9 Market Breakup by Indication
9.1 Arrhythmias
9.2 Myocardial Ischemia
9.3 Acute Myocardial Infarction
9.4 Congestive Heart Failure
9.5 Others
10 Market Breakup by Region
10.1 North America
10.2 Europe
10.3 Asia Pacific
10.4 Middle East and Africa
10.5 Latin America
11 Global Cardiovascular Implants Industry: SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Global Cardiovascular Implants Industry: Value Chain Analysis
13 Global Cardiovascular Implants Industry: Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Global Cardiovascular Implants Industry: Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Biotronik
15.3.2 Abbott Laboratories
15.3.3 AMG International
15.3.4 B-Braun
15.3.5 Johnson & Johnson
15.3.6 W.L. Gore & Associates
15.3.7 Medtronic
15.3.8 Boston Scientific
15.3.9 Sorin
15.3.10 Edwards Lifesciences
15.3.11 Fortimedix
15.3.12 Neovasc Inc.
15.3.13 On-X Life Technologies
15.3.14 Proxy Biomedical
15.3.15 Reva Medical
15.3.16 Shree Pacetronix Ltd.
For more information about this report visit https://www.researchandmarkets.com/research/3jgczh/global?w=4
